Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Roche Officially Launches Avastin after Fake Version Caused Problems

publication date: Sep 29, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai Roche Pharma, the first China JV set up by Roche, officially announced on its website that its cancer treatment Avastin has been approved for sale in China. The announcement comes after Avastin received negative publicity in China. Apparently, a fake version of Avastin caused adverse reactions in 61 patients at Shanghai No. 1 People's Hospital. More details....

Stock Symbol: (VX: ROG)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners